Amedisys Reports Third Quarter 2020 Financial Results - Updates 2020 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Amedisys (AMED) Tops Q3 EPS by 96c
October 28, 2020 4:06 PM EDTAmedisys (NASDAQ: AMED) reported Q3 EPS of $2.24, $0.96 better than the analyst estimate of $1.28. Revenue for the quarter came in at $544.1 million versus the consensus estimate of $533.18 million.
Paul B. Kusserow, President and Chief Executive Officer stated, I am very proud of our third quarter results which have bested both our internal and external... More



